$IVAC
INTEVAC INC

2024 Q1 Form 10-K Financial Statement

#000119312524037524 Filed on February 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $9.631M $12.91M $52.67M
YoY Change 20.07% 36.71%
Cost Of Revenue $5.427M $6.968M $32.44M
YoY Change 18.91% 3.12%
Gross Profit $4.204M $5.939M $20.23M
YoY Change 21.45% 186.2%
Gross Profit Margin 43.65% 46.01% 38.41%
Selling, General & Admin $4.281M $4.064M $18.35M
YoY Change -14.28% 5.53%
% of Gross Profit 101.83% 68.43% 90.7%
Research & Development $4.369M $3.785M $15.13M
YoY Change 14.32% 24.12%
% of Gross Profit 103.92% 63.73% 74.78%
Depreciation & Amortization $558.0K $398.0K $1.402M
YoY Change 20.97% -59.43%
% of Gross Profit 13.27% 6.7% 6.93%
Operating Expenses $8.650M $7.849M $33.47M
YoY Change -2.52% 13.19%
Operating Profit -$4.446M -$1.910M -$13.24M
YoY Change -39.6% -41.15%
Interest Expense $2.221M $536.0K $2.343M
YoY Change 29.78% -6608.33%
% of Operating Profit
Other Income/Expense, Net $1.500M -$2.000K -$53.00K
YoY Change -200.0% -276.67%
Pretax Income -$2.225M -$1.376M -$10.79M
YoY Change -49.95% -52.01%
Income Tax $476.0K $524.0K $1.822M
% Of Pretax Income
Net Earnings -$1.606M -$1.845M -$12.19M
YoY Change -42.99% -145.79%
Net Earnings / Revenue -16.68% -14.29% -23.15%
Basic Earnings Per Share -$0.06 -$0.47
Diluted Earnings Per Share -$0.06 -$0.07 -$0.47
COMMON SHARES
Basic Shares Outstanding 26.58M 26.37M 26.12K
Diluted Shares Outstanding 26.52K 26.12K

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.84M $68.85M $68.85M
YoY Change -33.02% -39.05%
Cash & Equivalents $45.75M $51.44M $32.39M
Short-Term Investments $18.09M $17.41M $17.41M
Other Short-Term Assets $2.387M $2.123M $2.123M
YoY Change 15.38% 16.2%
Inventory $45.81M $43.80M $43.80M
Prepaid Expenses
Receivables $25.14M $18.61M $18.61M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $137.2M $133.4M $133.4M
YoY Change -0.35% -1.08%
LONG-TERM ASSETS
Property, Plant & Equipment $7.149M $7.664M $15.32M
YoY Change 117.3% 65.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $922.0K $2.687M $2.687M
YoY Change -87.39% -63.82%
Other Assets $3.894M $4.166M $4.166M
YoY Change -23.57% -33.18%
Total Long-Term Assets $20.07M $23.13M $23.13M
YoY Change -33.99% 0.82%
TOTAL ASSETS
Total Short-Term Assets $137.2M $133.4M $133.4M
Total Long-Term Assets $20.07M $23.13M $23.13M
Total Assets $157.2M $156.5M $156.5M
YoY Change -7.33% -0.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.494M $5.800M $5.800M
YoY Change -15.88% 9.02%
Accrued Expenses $1.955M $1.820M $5.753M
YoY Change -62.67% -45.25%
Deferred Revenue $23.04M $20.41M
YoY Change -13.26%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $34.23M $32.51M $32.51M
YoY Change -23.1% 64.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $14.00K $21.00K $8.479M
YoY Change -74.7% 109.98%
Total Long-Term Liabilities $8.087M $8.479M $8.479M
YoY Change 266.42% 109.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.23M $32.51M $32.51M
Total Long-Term Liabilities $8.087M $8.479M $8.479M
Total Liabilities $42.32M $40.99M $40.99M
YoY Change -8.08% 72.56%
SHAREHOLDERS EQUITY
Retained Earnings -$66.98M -$65.38M
YoY Change 30.7%
Common Stock $211.4M $210.3M
YoY Change 2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.55M $29.55M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $114.9M $115.5M $115.5M
YoY Change
Total Liabilities & Shareholders Equity $157.2M $156.5M $156.5M
YoY Change -7.33% -0.8%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.606M -$1.845M -$12.19M
YoY Change -42.99% -145.79%
Depreciation, Depletion And Amortization $558.0K $398.0K $1.402M
YoY Change 20.97% -59.43%
Cash From Operating Activities -$6.535M $5.857M -$35.07M
YoY Change -61.6% -12716.19%
INVESTING ACTIVITIES
Capital Expenditures $566.0K $491.0K $5.431M
YoY Change -191.26% -553.34%
Acquisitions $0.00
YoY Change
Other Investing Activities $1.188M $2.212M $23.71M
YoY Change -26.63% -67.25%
Cash From Investing Activities $622.0K $1.721M $18.28M
YoY Change -30.52% -74.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.365M
YoY Change -48.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 318.0K -54.00K -624.0K
YoY Change -108.65% -132.88%
NET CHANGE
Cash From Operating Activities -6.535M 5.857M -35.07M
Cash From Investing Activities 622.0K 1.721M 18.28M
Cash From Financing Activities 318.0K -54.00K -624.0K
Net Change In Cash -5.691M 7.524M -17.55M
YoY Change -59.0% -123.92%
FREE CASH FLOW
Cash From Operating Activities -$6.535M $5.857M -$35.07M
Capital Expenditures $566.0K $491.0K $5.431M
Free Cash Flow -$7.101M $5.366M -$40.50M
YoY Change -66.02% -2844.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001001902
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-26946
CY2023 dei Entity Registrant Name
EntityRegistrantName
INTEVAC, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3125814
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3560 Bassett Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95054
CY2023 dei City Area Code
CityAreaCode
408
CY2023 dei Local Phone Number
LocalPhoneNumber
986-9888
CY2023 dei Security12b Title
Security12bTitle
Common Stock
CY2023 dei Trading Symbol
TradingSymbol
IVAC
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
95061431
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26576160
CY2023 dei Auditor Firm
AuditorFirmId
207
CY2023 dei Auditor Name
AuditorName
San Jose
CY2023 dei Auditor Location
AuditorLocation
California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51441000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68904000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
17405000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25541000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18613000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
15823000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Inventory Net
InventoryNet
43795000
CY2022Q4 us-gaap Inventory Net
InventoryNet
30003000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2123000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1898000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
133377000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
142169000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7664000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3658000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7658000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3390000
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2687000
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
17585000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
700000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
786000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
954000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1090000
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
3466000
CY2022Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
4381000
CY2023Q4 us-gaap Assets
Assets
156506000
CY2022Q4 us-gaap Assets
Assets
173059000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1008000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3404000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5800000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11610000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3475000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3087000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1820000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5430000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20407000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2444000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32510000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25975000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6976000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1417000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1482000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22215000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8479000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
23632000
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26396
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26396
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25548
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25548
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
26000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
210320000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
206355000
CY2022Q4 ivac Treasury Stock Share
TreasuryStockShare
5087
CY2023Q4 ivac Treasury Stock Share
TreasuryStockShare
5087
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
29551000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
29551000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
97000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-193000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65375000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53185000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
115517000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
123452000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156506000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173059000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52665000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35761000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32439000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20675000
CY2023 us-gaap Gross Profit
GrossProfit
20226000
CY2022 us-gaap Gross Profit
GrossProfit
15086000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15125000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13722000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18345000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17876000
CY2023 us-gaap Operating Expenses
OperatingExpenses
33470000
CY2022 us-gaap Operating Expenses
OperatingExpenses
31598000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-13244000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-16512000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2509000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1240000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-155000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10788000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15427000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1822000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1327000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12610000
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-16754000
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
420000
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-321000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12190000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17075000
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.48
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.48
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.67
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.67
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.02
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.02
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26121
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26121
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25192
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25192
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12190000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17075000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
422000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-454000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-132000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-317000
CY2023 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
290000
CY2022 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-771000
CY2023 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2022 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
290000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-771000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11900000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17846000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
134015000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1873000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1244000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
724000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4890000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17075000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-771000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
123452000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
272000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1059000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1739000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4373000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12190000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
290000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
115517000
CY2023 us-gaap Profit Loss
ProfitLoss
-12190000
CY2022 us-gaap Profit Loss
ProfitLoss
-17075000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1402000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1446000
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
191000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
196000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
136000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4373000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4890000
CY2023 ivac Straight Line Rent Adjustments And Amortization Of Lease Incentives
StraightLineRentAdjustmentsAndAmortizationOfLeaseIncentives
-1105000
CY2022 ivac Straight Line Rent Adjustments And Amortization Of Lease Incentives
StraightLineRentAdjustmentsAndAmortizationOfLeaseIncentives
-843000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
41000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1467000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1014000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
836000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2824000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1528000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13792000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24105000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
324000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-42000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5810000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6290000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2951000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1266000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2770000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
22552000
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-22883000
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
9641000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35073000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7434000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14780000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
52385000
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
38427000
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
26649000
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
65000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
763000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
5431000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1919000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18281000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28418000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1365000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3083000
CY2023 ivac Payment Of Acquisition Related Contingent Consideration
PaymentOfAcquisitionRelatedContingentConsideration
250000
CY2022 ivac Payment Of Acquisition Related Contingent Consideration
PaymentOfAcquisitionRelatedContingentConsideration
0
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1739000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
724000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-624000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2359000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-133000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-331000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17549000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69690000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103514000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52141000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69690000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
820000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
569000
CY2023 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
5000
CY2022 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0
CY2023 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 2%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal Year End Date </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;text-align:justify">Intevac operates under a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">52-53</div> week fiscal year ending on the Saturday nearest to December 31 of each year in order to improve the alignment of financial and business processes and to streamline financial reporting. Each fiscal quarter consists of 13 weeks, with an occasional fourth quarter extending to 14 weeks, if necessary, for the fiscal year to end on the Saturday nearest to December 31. The Company’s fiscal 2023 and fiscal 2022 years ended on December 30, 2023 and December 31, 2022, respectively. </div>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-165000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-186000
CY2022 ivac Disopsal Group Including Discontinued Operation Other Income Expense Discontinued Operations
DisopsalGroupIncludingDiscontinuedOperationOtherIncomeExpenseDiscontinuedOperations
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-321000
CY2023 ivac Equity Based Compensation Discontinued Operation
EquityBasedCompensationDiscontinuedOperation
-260000
CY2022 ivac Equity Based Compensation Discontinued Operation
EquityBasedCompensationDiscontinuedOperation
-229000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52665000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35761000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52665000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35761000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22265000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
27105000
CY2023 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-4840000
CY2023 ivac Notes Receivable Numberof Installments
NotesReceivableNumberofInstallments
3
CY2023Q2 ivac Cancellation Order Received And Obligation Thereof
CancellationOrderReceivedAndObligationThereof
54600000
CY2023Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
19100000
CY2023Q3 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
444000
CY2023Q4 ivac Cancellation Order Received And Obligation Thereof
CancellationOrderReceivedAndObligationThereof
11400000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
42400000
CY2023 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
we also refer to as backlog and expect to recognize as revenue: 79% in 2024 and 21% in 2025.
CY2023 ivac Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio
1
CY2023Q4 ivac Exercise Price Of Share Options As Percentage Of Fair Market Value Minimum
ExercisePriceOfShareOptionsAsPercentageOfFairMarketValueMinimum
1
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6500000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2030-05-13
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
CY2023 ivac Share Based Compensation Arrangement By Share Based Payment Award Options Offering Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOfferingPeriod
P2Y
CY2023 ivac Purchase Intervals Of Series
PurchaseIntervalsOfSeries
P6M
CY2023 ivac Maximum Employee Salary Withholdings For Purchase Of Common Stock Under Terms Of Espp
MaximumEmployeeSalaryWithholdingsForPurchaseOfCommonStockUnderTermsOfEspp
0.50
CY2023Q4 us-gaap Employee Stock Ownership Plan Esop Repurchase Obligation Amount
EmployeeStockOwnershipPlanESOPRepurchaseObligationAmount
25000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4373000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4890000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
383099
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
327711
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
188286
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.97
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
52813
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.15
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
142000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.57
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y6M25D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
900
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
141750
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.58
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M25D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
675
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
99000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
206000
CY2023 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
304000
CY2022 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
279000
CY2023 ivac Employee Stock Purchase Plans Shares Issued Weighted Average Price
EmployeeStockPurchasePlansSharesIssuedWeightedAveragePrice
3.48
CY2022 ivac Employee Stock Purchase Plans Shares Issued Weighted Average Price
EmployeeStockPurchasePlansSharesIssuedWeightedAveragePrice
4.46
CY2023 ivac Stock Issued During Period Employee Stock Purchase Plans Rights Exercised Aggregate Intrinsic Value
StockIssuedDuringPeriodEmployeeStockPurchasePlansRightsExercisedAggregateIntrinsicValue
463000
CY2022 ivac Stock Issued During Period Employee Stock Purchase Plans Rights Exercised Aggregate Intrinsic Value
StockIssuedDuringPeriodEmployeeStockPurchasePlansRightsExercisedAggregateIntrinsicValue
220000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-12610000
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-16754000
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
420000
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-321000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12190000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-17075000
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
26121
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
25192
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26121
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25192
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.48
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.48
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.67
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.67
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.02
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.02
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
18220000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15399000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
393000
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
424000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18613000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
15823000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
37346000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19116000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6449000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9499000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1388000
CY2023Q4 us-gaap Inventory Net
InventoryNet
43795000
CY2022Q4 us-gaap Inventory Net
InventoryNet
30003000
CY2023Q2 ivac Cancellation Order Received And Obligation Thereof
CancellationOrderReceivedAndObligationThereof
54600000
CY2023Q4 ivac Cancellation Order Received And Obligation Thereof
CancellationOrderReceivedAndObligationThereof
11400000
CY2023Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
19100000
CY2023Q2 ivac Inventory To Take Delivery
InventoryToTakeDelivery
12500000
CY2023Q2 ivac Inventory Reimburse
InventoryReimburse
3200000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29923000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28583000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22259000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24925000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7664000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3658000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7664000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3658000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3342000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4356000
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
124000
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
25000
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
3466000
CY2022Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
4381000
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
93000
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
99000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
947000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
838000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
376000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2446000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
184000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
163000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
174000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
187000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
139000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
216000
CY2023Q4 ivac Litigation Settlement
LitigationSettlement
0
CY2022Q4 ivac Litigation Settlement
LitigationSettlement
1012000
CY2023Q4 ivac Accrued Restructuring
AccruedRestructuring
0
CY2022Q4 ivac Accrued Restructuring
AccruedRestructuring
318000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
0
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
250000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1820000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5430000
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
21000
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
0
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
71595000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
64000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
71533000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
112514000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
484000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
112030000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
49855000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
49796000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2690000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2687000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
52545000
CY2023Q4 us-gaap Debt Securities
DebtSecurities
52483000
CY2023Q4 us-gaap Debt Securities Available For Sale Term
DebtSecuritiesAvailableForSaleTerm
P3Y
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
70
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
19251000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
7501000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
58000
CY2023 us-gaap Average Remaining Maturity Of Foreign Currency Derivatives1
AverageRemainingMaturityOfForeignCurrencyDerivatives1
P30D
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
0
CY2013Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000
CY2018Q3 ivac Stock Repurchase Program Acquired Authorized Amount
StockRepurchaseProgramAcquiredAuthorizedAmount
10000000
CY2018Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
40000000
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
10400000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-121000
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-121000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2023 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
3000
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
4000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
805000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
490000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
1014000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
954000
CY2023 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
1819000
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
1444000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1822000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1327000
CY2023 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2022 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
1822000
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Discontinued Operations Extraordinary Items
IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems
1327000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17089000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-20570000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
6301000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
5143000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10788000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15427000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.169
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.086
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
312000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
525000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
283000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
229000
CY2023Q4 ivac Deferred Tax Assets Other Finite Lived Assets
DeferredTaxAssetsOtherFiniteLivedAssets
29000
CY2022Q4 ivac Deferred Tax Assets Other Finite Lived Assets
DeferredTaxAssetsOtherFiniteLivedAssets
14000
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
304000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1116000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
851000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
841000
CY2023Q4 ivac Lease Liability
LeaseLiability
2101000
CY2022Q4 ivac Lease Liability
LeaseLiability
898000
CY2023Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
4701000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
2440000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
53940000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
56310000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
53000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62574000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62380000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56923000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
57310000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5651000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5070000
CY2023Q4 ivac Deferred Tax Liabilities Intangible Asset Amortization
DeferredTaxLiabilitiesIntangibleAssetAmortization
283000
CY2022Q4 ivac Deferred Tax Liabilities Intangible Asset Amortization
DeferredTaxLiabilitiesIntangibleAssetAmortization
160000
CY2023Q4 ivac Rou Asset
RouAsset
2026000
CY2022Q4 ivac Rou Asset
RouAsset
554000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2309000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
714000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3342000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4356000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3342000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4356000
CY2018 ivac Number Of Foreign Subsidiaries For Which Provision For One Time Transition Tax Recorded
NumberOfForeignSubsidiariesForWhichProvisionForOneTimeTransitionTaxRecorded
7
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2266000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3240000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-266000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-219000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1009000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
788000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
5039000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2441000
CY2023 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
0
CY2022 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1822000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1327000
CY2023Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
1900000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7600000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1008000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
730000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
718000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
430000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
12000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6448000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
9000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7599000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
730000
CY2022 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023 ivac Defined Contribution Plan Employee Eligibility Age
DefinedContributionPlanEmployeeEligibilityAge
P18Y
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
154000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
151000
CY2023 ivac Defined Bonus Plan Cost Recognized
DefinedBonusPlanCostRecognized
1400000
CY2022 ivac Defined Bonus Plan Cost Recognized
DefinedBonusPlanCostRecognized
1200000
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
293000
CY2022Q1 ivac Operating Lease First Instalment Payments
OperatingLeaseFirstInstalmentPayments
308000
CY2022Q1 ivac Number Of Operating Lease Payments
NumberOfOperatingLeasePayments
7
CY2022Q1 ivac Operating Lease Quarterly Instalment Payments
OperatingLeaseQuarterlyInstalmentPayments
259000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7658000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3390000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3404000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6976000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1417000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7984000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4821000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1613000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1624000
CY2023 ivac Operating Lease Cost Subleased Assigned Property
OperatingLeaseCostSubleasedAssignedProperty
869000
CY2022 ivac Operating Lease Cost Subleased Assigned Property
OperatingLeaseCostSubleasedAssignedProperty
974000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
125000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
43000
CY2023 us-gaap Sublease Income
SubleaseIncome
869000
CY2022 us-gaap Sublease Income
SubleaseIncome
974000
CY2023 us-gaap Lease Cost
LeaseCost
1738000
CY2022 us-gaap Lease Cost
LeaseCost
1667000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1631000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2110000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1852000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1799000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1841000
CY2023Q4 ivac Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
786000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10019000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2035000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7984000
CY2023Q4 ivac Tenant Improvement Allowance Receivable
TenantImprovementAllowanceReceivable
292000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M8D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0837
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0581
CY2023 ivac Operating Lease Payment
OperatingLeasePayment
1831000
CY2022 ivac Operating Lease Payment
OperatingLeasePayment
1757000
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
6520000
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1122000
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
700000
CY2023Q4 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
700000
CY2023 ivac Minimum Product Warranty Range
MinimumProductWarrantyRange
P12M
CY2023 ivac Maximum Product Warranty Range
MaximumProductWarrantyRange
P24M
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
163000
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
346000
CY2023 us-gaap Product Warranty Expense
ProductWarrantyExpense
214000
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
312000
CY2023 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
262000
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
147000
CY2023 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-6000
CY2022 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-18000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
205000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
163000
CY2022 us-gaap Restructuring Costs
RestructuringCosts
1200000
CY2022 ivac Savings In Stock Based Compensation Pursuant To Restructuring
SavingsInStockBasedCompensationPursuantToRestructuring
1300000
CY2022 ivac Cost Of Disposal Of Fixed Assets
CostOfDisposalOfFixedAssets
1500000
CY2022 ivac Inventory Writeoff
InventoryWriteoff
755000
CY2022 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.06
CY2022 ivac Expected Decrease In Expenses Due To Reduction In Workforce
ExpectedDecreaseInExpensesDueToReductionInWorkforce
2100000
CY2022Q2 ivac Other Employee Benefits Expense
OtherEmployeeBenefitsExpense
693000
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1200000
CY2022Q1 us-gaap Other Commitment
OtherCommitment
665000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2100000
CY2022Q1 ivac Operating Lease First Instalment Payments
OperatingLeaseFirstInstalmentPayments
308000
CY2022Q1 ivac Number Of Operating Lease Payments
NumberOfOperatingLeasePayments
7
CY2022Q1 ivac Operating Lease Quarterly Instalment Payments
OperatingLeaseQuarterlyInstalmentPayments
259000
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1200000
CY2022Q1 us-gaap Other Commitment
OtherCommitment
665000
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
1023000
CY2022 us-gaap Restructuring Charges
RestructuringCharges
1232000
CY2022 us-gaap Payments For Restructuring
PaymentsForRestructuring
1269000
CY2022 ivac Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
37000
CY2022Q4 ivac Provision For Restructuring Charges Associated With Photonics Sale A
ProvisionForRestructuringChargesAssociatedWithPhotonicsSaleA
127000
CY2022 ivac Payments Made For Restructuring One
PaymentsMadeForRestructuringOne
757000
CY2022 ivac Restructuring Reserve Settled Without Cash2one
RestructuringReserveSettledWithoutCash2one
-75000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
318000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
1950000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
1948000
CY2023 ivac Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
2000
CY2023Q4 ivac Provision For Restructuring Charges Associated With Photonics Sale A
ProvisionForRestructuringChargesAssociatedWithPhotonicsSaleA
7000
CY2023 ivac Payments Made For Restructuring One
PaymentsMadeForRestructuringOne
325000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
250000
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
250000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
67000
CY2022Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y3M18D
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
136000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1132000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1132000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
42000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
954000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1090000
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001193125-24-037524-index-headers.html Edgar Link pending
0001193125-24-037524-index.html Edgar Link pending
0001193125-24-037524.txt Edgar Link pending
0001193125-24-037524-xbrl.zip Edgar Link pending
d727242d10k.htm Edgar Link pending
d727242dex211.htm Edgar Link pending
d727242dex231.htm Edgar Link pending
d727242dex311.htm Edgar Link pending
d727242dex312.htm Edgar Link pending
d727242dex321.htm Edgar Link pending
d727242dex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivac-20231230.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
ivac-20231230_def.xml Edgar Link unprocessable
ivac-20231230_cal.xml Edgar Link unprocessable
ivac-20231230_lab.xml Edgar Link unprocessable
ivac-20231230_pre.xml Edgar Link unprocessable
d727242d10k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable